Merck finishes animal vaccine plant overhaul

Merck ($MRK) has completed its expansion and renovation of an Elkhorn, NE, animal vaccine plant and will begin transferring researchers from its Delaware site to the newly improved facility. The company has spent $13.5 million renovating the plant, adding a high-speed vaccine vial filling line and disinfection chambers. Story